Psychedelic Co. Wins Proxy Victory Against Activist FCM
Psychedelic drug company MindMed, advised by Cooley and Latham & Watkins, announced Wednesday that all of its board of directors nominees had been elected, in a rebuke to activist investor FCM,...To view the full article, register now.
Already a subscriber? Click here to view full article